- Case report
- Open Access
Giant renal oncocytoma: a case report and review of the literature
Journal of Medical Case Reports volume 4, Article number: 52 (2010)
Renal oncocytomas are benign neoplasms derived from cells of the distal renal tubule, and comprise 5% to 7% of primary renal neoplasms. Oncocytomas are mostly asymptomatic, and the majority of tumors are discovered incidentally. In this case report, we present a case of a patient with a giant oncocytoma arising from her left kidney.
We describe a 25-year-old Turkish woman who was admitted to our hospital with abdominal pain and a 3-year palpable abdominal mass, which was found present since her second pregnancy. Examination revealed a 15 × 20-cm mass in her abdominal cavity. Computed tomography revealed a mass with regular outlines, measuring 18 × 11 × 12 cm, associated with the left kidney, and causing marked hydroureteronephrosis. We excised the mass and performed a left nephrectomy on our patient. The immunohistopathology of the mass was consistent with renal oncocytoma. No local or distant metastasis was seen at 6 months postoperatively.
To the best of our knowledge, this is the second largest renal oncocytoma described in the English language literature. This is also the first reported giant oncocytoma that presented during pregnancy.
Oncocytomas are benign, nonurothelial, epithelial tumors that constitute 5% to 7% of primary renal neoplasms. Classically, an oncocytoma is a solid mass that develops in the renal parenchyma and has a central fibrous scar [1, 2]. Most are asymptomatic at presentation and are discovered only incidentally during evaluation of non-urological problems, but hematuria and pain occur in a minority of documented cases .
A 25-year-old Turkish woman was admitted to our hospital in October 2008. She was suffering from abdominal pain, weakness, anorexia, and a 7-kg to 8-kg weight loss. It was discovered that she had a palpable abdominal mass three years prior to presentation. Physical examination revealed a 15 × 20-cm mass with regular contours in the her periumbilical region (Figure 1). Four years prior to presentation, during her second pregnancy, she was admitted to a hospital because of abdominal pain, and an ultrasonographic examination then revealed an abdominal mass. As she did not want to terminate her pregnancy, she declined to undergo further examinations. After her pregnancy, she was told by her doctor that the mass had grown markedly. Because she was afraid of regularly visiting a doctor, she treated herself using alternative medicines such as eucalyptus tea, bay leaves and oleander. She claimed that drinking this tea made the mass shrink.
Her laboratory results at the time of presentation were as follows: hemoglobin, 13 g/dl; white blood cell count, 10,500/cm3; platelets, 302,000/cm3; sodium, 135 mEq/L; potassium, 4.1 mEq/L; blood urea nitrogen, 28 mg/dl; creatinine, 1.1 mg/dl; glucose, 110 mg/dl; aspartate aminotransferase (AST), 36 IU/L; and alanine aminotransferase (ALT), 41 IU/L. On abdominal X-rays, all of her intestines were seen shifted to the right. An intravenous pyleogram (IVP) showed a mass associated with her left kidney. Abdominal computed tomography (CT) and magnetic resonance imaging (MRI) revealed an 18 × 11 × 12-cm mass located in the middle of her left kidney and extending inferiorly, with diffuse contrast enhancement (Figures 2 to 3). The mass was consistent with renal cell carcinoma on CT. Owing to the mass, she develped left hydroureteronephrosis (Figure 4). Her right kidney appeared to be within normal limits on the IVP and CT examinations. A laparotomy was performed via a midline incision. A 25 × 16 × 12 cm, 3380 g mass, arising from the left kidney and shifting the ureter proximally, was excised together with the left kidney (Figures 5, 6, 7). Our patient was discharged on the sixth postoperative day, with no signs of complications.
Meanwhile, microscopic examination of hematoxylin and eosin (H&E)-stained sections at low power showed a neoplasm with a pseudocapsule and a tubulocystic pattern divided by thin fibrous septa. At higher magnification, the cells appeared to be round to polygonal with abundant granular eosinophilic cytoplasm, a regular round nucleus, and a central nucleolus. There were no foci of clear cell changes, necrosis, or mitotic figures.
Renal oncocytoma was initially described in 1942 by Zippel. Oncocytomas are benign tumors of the kidney that are usually diagnosed postoperatively, after an erroneous diagnosis of renal cell carcinoma (RCC).
A summary of the studies about giant oncocytomas published in the English literature is presented as Additional File 1. To date, Demos et al.  have reported the largest and heaviest oncocytoma, which measured 27 × 20 × 15 cm and weighed 4652 g and Sundararajan et al.  reported the second heaviest renal oncocytoma (3353 g, 20 cm in size). Meanwhile, Banks et al.  reported the third heaviest renal oncocytoma (3090 g, 21 × 18 × 15 cm) and Kilic et al.  reported the fourth heaviest oncocytoma (2680 g, 20 × 15 × 10 cm). We report what we believe is now the second largest renal oncocytoma, a mass weighing 3380 g and measuring 25 × 15 × 12 cm.
Renal oncocytomas are uncommon and consist of a pure population of oncocytes, which are large well-differentiated neoplastic cells with intensely eosinophilic granular cytoplasm due to the large number of mitochondria [8–10]. Like chromophobe carcinomas, oncocytomas appear to originate from collecting duct cells . In most cases, oncocytomas and different histological subtypes of RCC can be differentiated on gross inspection and from H&E-stained microscopic slides. Sometimes the differentiation is difficult, especially that among the eosinophilic variant of chromophobe RCC, the granular variant of conventional RCC, and oncocytoma [11, 12].
The most useful marker for the differentiation of renal tumors are vimentin (positive in conventional renal cell carcinoma and negative in chromophobe cell carcinoma and oncocytoma), CK7 (positive in chromophobe cell carcinoma and negative in oncocytoma and conventional renal cell carcinoma), RCC marker and CD10 (positive in conventional renal cell carcinoma and negative in chromophobe cell carcinoma and oncocytoma), and Hale's colloidal iron staining with diffuse reticular pattern and perinuclear halo (which is present in chromophobe cell carcinoma but absent in oncocytoma and conventional renal cell carcinoma) [13–16]. The distal nephron proteins claudin-7 and claudin-8 have potential use as immunohistochemical biomarkers in the differential diagnosis of chromophobe renal cell carcinoma and oncocytoma . Homogeneous epithelial cell adhesion molecule (EpCAM) expression confirms the diagnosis of chromophobe carcinoma rather than oncocytoma.
Oncocytomas can appear on CT and ultrasound as a central scar located within a homogeneous, well-circumscribed solid mass . However, this is considered nonspecific and occurs in only 33% of cases of oncocytomas [2, 3]. In addition, this finding does not exclude clear cell carcinoma. In our case, no such central scar was seen on CT. Furthermore, the mass was hypervascular. As such, differentiating oncocytoma and RCC in preoperative imaging studies remains difficult. Moreover, RCC can coexist with oncocytoma.
Renal oncocytomas are almost invariably benign and no cases of metastasis have been reported. Even when very large, they are generally well encapsulated and are rarely invasive or associated with metastases . In our case, no relapse occurred in the first 6 months postoperatively. This benign nature has important therapeutic implications, and oncocytoma should be considered in the differential diagnosis of patients with small renal masses discovered incidentally or with tumors found within a solitary kidney. Despite their benign behavior, however, oncocytomas should be monitored closely and treated if there is evidence of rapid growth or a coexisting RCC, which occurs in 10% to 32% of reported patients , because progressive growth can destroy the adjacent renal parenchyma and may constitute another indication for therapeutic intervention .
Renal oncocytoma has a benign clinical course with excellent long-term outcomes. Surgical treatment of renal tumors is still unclear. Although radical surgery has been employed in the past as principal therapy, more precise preoperative and peri-operative diagnosis should allow more frequent use of conservative surgery, such as partial nephrectomy or tumor excision. Conservative management such as organ-sparing surgery or partial nephrectomy should be reserved for bilateral tumors or where the tumor occurs in a solitary kidney [16, 19].
Although there have been many improvements in the histopathological diagnosis of giant oncocytoma, more case reports and studies are needed to understand the behavior, prognosis and treatment of this tumor.
Written informed consent was obtained from our patient for publication of this case report and any accompanying image. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
renal cell carcinoma
epithelial cell adhesion molecule
magnetic resonance imaging.
Amin MB, Crotty TB, Tickoo SK, Farrow GM: Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol. 1997, 21 (1): 1-12. 10.1097/00000478-199701000-00001.
Perez-Ordonez B, Hamed G, Campbell S, Erlandson RA, Russo P, Gaudin PB, Reuter VE: Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol. 1997, 21 (8): 871-883. 10.1097/00000478-199708000-00001.
Radopoulos D, Tzakas K, Tahmatzopoulos A: A rare case of renal oncocytoma associated with erythrocytosis: case report. BMC Urol. 2006, 6: 26-10.1186/1471-2490-6-26.
Demos TC, Malone AJ: Computed tomography of a giant renal oncocytoma. J Comp Assist Tomogr. 1988, 12 (5): 899-900.
Sundararajan S, Dyer J, Pemberton R, Cohen RJ: Asymptomatic giant renal oncocytoma presenting with hypertension. Pathol. 2008, 40 (7): 723-724. 10.1080/00313020802436865.
Banks KL, Cherullo EE, Novick AC: Giant renal oncocytoma. Urol. 2001, 57 (2): 365-366. 10.1016/S0090-4295(00)00913-4.
Kiliç S, Altinok MT, Ipek D, Ergin H: Case report of a giant renal oncocytoma. Int Urol Nephrol. 2003, 35 (1): 83-84. 10.1023/A:1025901807469.
Lieber MM: Renal oncocytoma: prognosis and treatment. Eur Urol. 1990, 18 (2): 17-21.
Zerban H, Nogueira E, Riedasch G, Bannasch P: Renal oncocytoma: origin from the collecting duct. Virchows Arch B Cell Pathol Incl Mol Pathol. 1987, 52 (5): 375-387.
Morra MN, Das S: Renal oncocytoma: a review of histogenesis, histopathology, diagnosis and treatment. J Urol. 1993, 150 (2): 295-302.
Crotty TB, Farrow GM, Leiber MM: Chromophobe cell renal carcinoma: clinicopathologic feature of 50 cases. J Urol. 1995, 154 (3): 964-967. 10.1016/S0022-5347(01)66944-1.
Cochand-Priollet B, Molinié V, Bougaran J, Bouvier R, Dauge-Geffroy MC, Deslignières S, Fournet JC, Gros P, Lesourd A, Saint-André JP, Toublanc M, Vieillefond A, Wassef M, Fontaine A, Groleau L: Renal chromophobe cell carcinoma and oncocytoma: a comparative morphologic, histological and immunohistochemial study of 124 cases. Arch Pathol Lab Med. 1997, 121 (10): 181-186.
Osunkoya AO, Cohen C, Lawson D, Picken MM, Amin MB, Young AN: Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma. Hum Pathol. 2009, 40 (2): 206-210. 10.1016/j.humpath.2008.07.002.
Geramizadeh B, Ravanshad M, Rahsaz M: Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma. Indian J Pathol Microbiol. 2008, 51 (2): 167-171. 10.4103/0377-4929.41641.
Skinnider BF, Folpe AL, Hennigar RA, Lim SD, Cohen C, Tamboli P, Young A, de Peralta-Venturina M, Amin MB: Distribution of cytokeratins and Vimentin in adult renal neoplasms and normal renal tissue. Am J Surg Pathol. 2005, 29 (6): 747-754. 10.1097/01.pas.0000163362.78475.63.
Langer C, Wegscheider BJ, Ratschek M, Schips L, Zigeuner R: Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 223 tumors. Virchows Arch. 2004, 444: 127-134. 10.1007/s00428-003-0948-2.
Shin LK, Badler RL, Bruno FM, Gupta M, Katz DS: Radiology-pathology conference: bilateral renal oncocytomas. Clin Imaging. 2004, 28 (5): 344-348. 10.1016/j.clinimag.2004.04.002.
Dechet CB, Bostwick DG, Blute ML, Bryant SC, Zincke H: Renal oncocytoma: multifocality, bilateralism, metachronous tumor development, and coexistent renal cell carcinoma. J Urol. 1999, 162 (1): 40-42. 10.1097/00005392-199907000-00010.
Chao DH, Zisman A, Pantuck AJ, Freedland SJ, Said JW, Belldegrun AS: Changing concepts in the management of renal oncocytoma. Urol. 2002, 59 (5): 635-642. 10.1016/S0090-4295(01)01630-2.
Neuzillet Y, Lechevallier E, Andre M, Daniel L, Nahon O, Coulange C: Follow-up of renal oncocytoma diagnosed by percutaneous tumor biopsy. Urol. 2005, 66 (6): 1181-1185. 10.1016/j.urology.2005.06.001.
The authors declare that they have no competing interests.
SA and BC performed the surgical procedure, contributed in writing the article and review of the literature, and undertook a comprehensive literature search. SA contributed in the design of the study and preparation of the manuscript. ARS provided the histopathological information and AS provided the radiological information. All authors read and approved the final manuscript
Electronic supplementary material
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Akbulut, S., Senol, A., Cakabay, B. et al. Giant renal oncocytoma: a case report and review of the literature. J Med Case Reports 4, 52 (2010). https://doi.org/10.1186/1752-1947-4-52
- Renal Cell Carcinoma
- Partial Nephrectomy
- Chromophobe Renal Cell Carcinoma
- Central Scar
- Renal Oncocytoma